NCT00391261View on ClinicalTrials.gov

An Open-label Trial of Metformin for Weight Control of Pediatric Patients on Antipsychotic Medications.

PHASE4CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
SchizophreniaSchizoaffective DisorderSchizophreniform DisorderBipolar DisorderAutism Spectrum Disorders
Interventions
DRUG

Metformin

open-label, flexible dosing

Trial Locations (1)

02155

Cambridge Health Alliance, Medford

All Listed Sponsors
collaborator

American Psychiatric Association

OTHER

lead

Cambridge Health Alliance

OTHER

NCT00391261 - An Open-label Trial of Metformin for Weight Control of Pediatric Patients on Antipsychotic Medications. | Biotech Hunter | Biotech Hunter